www.nejm.org/doi/full/10....
"In this study, we describe a personalized base-editing therapy wholly developed in the 6-month span after a patient’s birth."
Base editors can correct disease-causing genetic variants. After a neonate had received a diagnosis of severe carbamoyl-phosphate synthetase 1 deficiency, a disease with an estimated 50% mortality ...
